Certara is a drug development company providing software, services, and modeling to help pharma, biotech, and CROs accelerate drugs from discovery through approval and market access. It serves drug developers integrating predictive simulation, data-driven modeling, and AI across clinical phases. Its tech has supported 100+ novel drug approvals and 325 label claims accepted in lieu of trials.
acquisitions n=0
No cited completed company acquisition recorded.
traction n=0
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
valuations n=0
No cited valuation with an explicit basis is recorded.
revenue multiples n=0
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.